Serial 79286383
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79286383
- Registration number
- 6331130
- Mark type
- Design / logo
- Filed
- 15 Apr 2020
- Published for opposition
- 09 Feb 2021
- Registered
- 27 Apr 2021
- Attorney of record
- Leigh Ann Lindquist
Goods and services
- Class 001 — Chemicals: Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions, derivatives, components and lysates thereof; chemical, biological, biochemical and biotechnological chemical products and preparations for laboratory or research use and manufacturing use, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions, derivatives, components and lysates thereof
- Class 005 — Pharmaceuticals: Chemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof; diagnostic preparations for medical and veterinary use; vaccines; healthcare preparations, medicines, medicinal preparations, pharmaceutical preparations and pharmaceutical substances for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; pharmaceutical preparations and substances, namely, adjuvants, carriers for active ingredients and drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents for medical use in humans or animals; biological implants comprising active ingredients
- Class 040 — Treatment of materials: Manufacture of pharmaceutical products, medicinal products, and medicaments from pharmaceutical compositions for others
- Class 042 — Scientific and technological services: Scientific research and development for others, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development as well as biotechnological research and development services for others with regard to manufacturing pharmaceutical preparations, implants comprising active ingredients, carriers for active ingredients and drug delivery systems for medical use in humans or animals; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for others
Owner
- NEUWAY Pharma GmbH, DE
- NEUWAY Pharma GmbH, Bonn, DE
- NEUWAY Pharma GmbH, Bonn, DE
Prosecution history
- 23 Apr 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 29 Aug 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 Aug 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 Aug 2021 — FINAL DISPOSITION PROCESSED
- 27 Jul 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Feb 2021 — PUBLISHED FOR OPPOSITION
- 06 Feb 2021 — NOTIFICATION PROCESSED BY IB
- 20 Jan 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 20 Jan 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 20 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jan 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jan 2021 — EXAMINER'S AMENDMENT ENTERED
- 04 Jan 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED